21 January 2014

Abcam to Open New Office in Shanghai, China

Cambridge, England - 21 January 2014 - Abcam plc will open a new office in Shanghai, China in February 2014. The new hub is the Company’s ninth global office, and has been established to support Abcam’s focus on increasing geographic reach and improving distribution channels to rapidly growing markets. Located in Zhangjiang Hi-Tech Park, Pudong New District, the office is within close proximity of the City and Abcam’s production facility in Hangzhou, which develops research tools such as RabMAb®, its proprietary rabbit monoclonal antibody technology.

The office will house customer and technical support functions, provided by native Mandarin speakers, as well as a product warehouse, which will facilitate local stock storage for the first time. The proximity of the office will also enable Abcam to support customers with more specific needs through its extensive range of products and services, including custom antibody production.

Dr Jonathan Milner, CEO, Abcam, said: “China is an important market for Abcam and we’re pleased to provide enhanced services such as faster delivery and dedicated local language support to our customers. Further future investments will ensure we continue to deliver innovative products and services to enable scientists to discover more.”

Abcam plc is a global leader in the supply of innovative protein research tools, with a wide range of products and expert technical support, enabling scientists to analyse living cells at the molecular level and improving the understanding of health and disease.

Headquartered in Cambridge, UK, Abcam has nine global subsidiary offices enabling local services, multi-language support and next-day delivery to over 100 countries. The Company was founded in 1998, and now employs over 700 FTEs. Abcam was admitted to AIM in 2005 (AIM: ABC).

Source: Abcam